Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

9.73

+0.30 (3.18%)

At close: May 29, 2025, 4:00 PM

9.45

-0.28 (-2.88%)

After-hours: May 29, 2025, 7:44 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Fiscal year is January - December.